Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnering Agreement with INSOMNIS Media Limited

28 Oct 2015 07:00

RNS Number : 6403D
Phorm Corporation Limited
28 October 2015
 

28 October 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Partnering Agreement with INSOMNIS Media Limited

Channel sales partnership entered into with INSOMNIS to expand its technology footprint and improve global advertising campaign performance

Phorm (AIM:PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that, further to its interim results released on 30 September 2015, it has formally entered into a channel sales partnership with INSOMNIS Media Limited ("INSOMNIS").

 

INSOMNIS, a digital media business specialising in the delivery of behavioral targeting and performance campaign solutions for its clients, will seek to leverage Phorm's proprietary technology and machine learning algorithms to identify users through a first party approach leading to more effective targeting, personalised messaging and efficient overall campaign delivery.

 

Phorm's first party data platform technology sits above digital properties, off network supply sources and real-time bidding platforms, where it synthesises user data, develops profiles and addresses users personalised with content or advertising messages at the point where the user is engaging client's websites. Brands, publishers and programmatic sources can clearly benefit when known users are able to engage with personalised content and it is therefore more effective and efficient for both the inventory and demand sides of our clients' businesses. The Company's technology provides unparalleled insight and a holistic view into digital advertising dynamics such that agencies and advertisers can achieve optimal inventory control and return on their investment.

 

 

CEO of INSOMNIS, Mr Mike Moran, commented:

 

"Brand managers have become particularly focused on whether they are messaging to their desired user base, which is often difficult to prove in the context of online advertising. Issues like privacy and viewability are becoming increasingly important to advertisers when they choose their partner for their display targeting and retargeting activity.

"We have every confidence in Phorm's tech platform and our partnership with Phorm will enable us to present our campaign metrics to clients, knowing that we have utilised first party data to deliver the brand's specific user base most efficiently. This is precisely the area where the online advertising industry needed to evolve."

 

Phorm's CEO, Timothy Smith, added:

 

"Mike Moran, Paul Grundy and their colleagues at INSOMNIS possess a wealth of ad industry expertise and relationships. Together, we've already helped a brand and publishing client in the U.K. achieve a successful campaign, which has provided validation that our initial partnership is already yielding results. We now look forward to extending this initial track record of success to the U.S. market."

 

 

-Ends-

 

 

 

For Phorm information please contact:

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0)20 3397 6001

 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance

 

About Phorm

 

Phorm (PHRM:AIM) is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

 

For Insomnis Media information please contact:

 

BrandMee

Marie Ellis +44 (0)7454 222611

 

About Insomnis Media

 

INSOMNIS is a digital media business specialising in behavioural targeting and driving campaign performance.

 

We use market-leading technology, which learns about our advertiser's audience, both prior to and during a campaign, which allows us to continuously improve performance by modifying CPCs/CPMs to maximise efficiency and programmatic/RTB win rates.

 

Visit us at www.insomnis-media.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALDLLLEBFXFBQ
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.